BICYCLE THERAPEUTICS PLC-ADR (BCYC)

US0887861088 - ADR

24.58  -0.11 (-0.45%)

After market: 24.58 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
11.7M
12.61%		14.46M
23.59%		26.976M
86.56%		28.034M
3.92%
EBITDA
YoY % growth
-64.57M
-25.97%		-112.4M
-74.07%		-182.806M
-62.64%		-211.558M
-15.73%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-65.98M
-25.58%		-116.09M
-75.95%		-189.352M
-63.11%		-235.046M
-24.13%
Operating Margin
-563.93%-802.84%-701.93%-838.43%
EPS
YoY % growth
-2.69
-1.51%		-3.80
-41.26%		-5.13
-35.00%		-5.29
-3.09%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-1.33
5.69%
Revenue
Q2Q % growth		6.342M
-44.37%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-58.119M
-33.61%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.62
52.31%		-1.270.6551.12%
Q4 2023
Q2Q % growth		 -1.16
-14.85%		-1.260.107.79%
Q3 2023
Q2Q % growth		 -1.26
-31.25%		-1.19-0.07-5.45%
Q2 2023
Q2Q % growth		 -1.41
-56.67%		-1.32-0.09-6.88%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 19.53M
298.57%		6.15M13.38M217.56%
Q4 2023
Q2Q % growth		 5.331M
67.12%		7.278M-1.947M-26.75%
Q3 2023
Q2Q % growth		 5.35M
75.99%		13.35M-8M-59.93%
Q2 2023
Q2Q % growth		 11.4M
160.27%		4.676M6.724M143.80%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.15% -0.16% 0% 6.2%
Revenue-0.08% -19.34% 0% -15.29%